Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Postmenopause. Found 10 abstracts

Cristofanilli M, Valero V, Mangalik A, Royce M, Rabinowitz I, Arena FP, Kroener JF, Curcio E, Watkins C, Bacus S, Cora EM, Anderson E, Magill PJ. Phase II, randomized trial to compare anastrozole combined with gefitinib or placebo in postmenopausal women with hormone receptor-positive metastatic breast cancer. Clinical Cancer Research. 2010 Mar 15;16(6):1904-14.   PMCID: NIHMS352308
Balogh GA, Russo J, Mailo DA, Heulings R, Russo PA, Morrison P, Sheriff F, Russo IH. The breast of parous women without cancer has a different genomic profile compared to those with cancer. Int J Oncol. 2007 Nov;31(5):1165-75.
Jordan VC. Tamoxifen or raloxifene for breast cancer chemoprevention: a tale of two choices--point. Cancer Epidemiology, Biomarkers and Prevention. 2007 Nov;16(11):2207-9.
Jordan VC, Gelber RD. Problems with the progesterone receptor in practice?. J Clin Oncol. 2007 May 20;25(15):1957-9.
Swaby RF, Sharma CG, Jordan VC. SERMs for the treatment and prevention of breast cancer. Rev Endocr Metab Disord. 2007 Sep;8(3):229-39.
Russo IH. Cigarette smoking and risk of breast cancer in women. Lancet (London, England). 2002 Oct 05;360(9339):1033-4.
Winer EP, Hudis C, Burstein HJ, Chlebowski RT, Ingle JN, Edge SB, Mamounas EP, Gralow J, Goldstein LJ, Pritchard KI, Braun S, Cobleigh MA, Langer AS, Perotti J, Powles TJ, Whelan TJ, Browman GP. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002. J Clin Oncol. 2002 Aug;20(15):3317-27.
Dorgan JF, Baer DJ, Albert PS, Judd JT, Brown ED, Corle DK, Campbell WS, Hartman TJ, Tejpar AA, Clevidence BA, Giffen CA, Chandler DW, Stanczyk FZ, Taylor PR. Serum hormones and the alcohol-breast cancer association in postmenopausal women. Journal of the National Cancer Institute. 2001 May 02;93(9):710-5.
Dorgan JF, Boudou P, Stanczyk FZ, Longcope C, Tejpar AA, Falk RT, Schussler N, Stephenson HE. Sources of elevated serum androgens in postmenopausal women who develop breast cancer. Cancer Epidemiol Biomarkers Prev. 2001 Apr;10(4):407-10.
Zhang Y, Felson DT, Ellison RC, Kreger BE, Schatzkin A, Dorgan JF, Cupples LA, Levy D, Kiel DP. Bone mass and the risk of colon cancer among postmenopausal women: the Framingham study. American journal of epidemiology. 2001 Jan;153(1):31-7.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Postmenopause

Female Postmenopause Breast Neoplasms Human Aged therapeutic use pathology drug therapy Middle Age metabolism Tamoxifen adverse effects Adult Triazoles Premenopause etiology Middle Aged Disease-Free Survival blood Raloxifene 80 and over Aged Estrogen Receptors prevention & control Adjuvant Chemotherapy Non-US Gov't Support Hormonal Antineoplastic Agents Nitriles Case-Control Studies Progesterone Receptors epidemiology Risk Factors Epidermal Growth Factor Receptor Colonic Neoplasms Randomized Controlled Trials US Gov't Support-PHS Age Distribution Animal Double-Blind Method Population Surveillance Selective Estrogen Receptor Modulators Estrogens Quinazolines Cohort Studies Breast Xenobiotics United States Women's Health Apoptosis Adrenal Glands Antineoplastic Combined Chemotherapy Protocols Body Mass Index Expert Testimony Ethanol Prasterone Evidence-Based Medicine Bone Density Antineoplastic Combined Chemotherapy Anticarcinogenic Agents Ovary chemically induced enzymology physiology Sex Hormones Survival Analysis Androstenedione Gene Expression Profiling Estrogen Replacement Therapy Dehydroepiandrosterone Sulfate pharmacokinetics Lymphatic Metastasis erbB-2 Receptor Hormone-Dependent Neoplasms DNA Repair Survival Rate antagonists & inhibitors Longitudinal Studies Aromatase administration & dosage Clinical Trials as Topic Tissue Distribution Smoking Massachusetts Epidemiologic Research Design Enzyme Inhibitors Incidence Animal Disease Models Protocols Epithelium Prospective Studies genetics analogs & derivatives Sex Hormone-Binding Globulin Pregnancy Treatment Outcome analysis Neoplasm Metastasis Parity
Last updated on Monday, July 06, 2020